- Tytuł:
- [Chinese expert consensus on iruplinalkib for the treatment of locally advanced or metastatic ALK-positive non-small cell lung cancer (2024 edition)].
- Corporate Authors:
-
Medical Oncology Branch of China International Exchange and Promotive Association for Medical and Health Care
Chinese Association for Clinical Oncologists - Źródło:
- Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Mar 23; Vol. 46 (3), pp. 189-205.
- Typ publikacji:
- English Abstract; Journal Article
- MeSH Terms:
-
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Antineoplastic Agents*/adverse effectsAmides *
Propionates*
Humans ; Crizotinib/therapeutic use ; Consensus ; Receptor Protein-Tyrosine Kinases ; Protein Kinase Inhibitors/adverse effects